{"id":22464,"date":"2021-12-16T19:38:14","date_gmt":"2021-12-16T19:38:14","guid":{"rendered":"https:\/\/sbpt.org.br\/portal\/?p=22464"},"modified":"2021-12-16T19:38:14","modified_gmt":"2021-12-16T19:38:14","slug":"anvisa-vacina-infantil-covid-19","status":"publish","type":"post","link":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/","title":{"rendered":"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos"},"content":{"rendered":"<p style=\"text-align: justify\">Na quinta-feira (16\/12), a Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou a indica\u00e7\u00e3o da vacina Comirnaty (Pfizer-BioNTech COVID-19, BNT162b2) para a imuniza\u00e7\u00e3o contra Covid-19 de crian\u00e7as de 5 a 11 anos de idade.<\/p>\n<p style=\"text-align: justify\">Ap\u00f3s reuni\u00e3o realizada no dia 10\/12\/2021 com representantes da Anvisa e da Sociedade Brasileira de Pneumologia e Tisiologia (SBPT), Associa\u00e7\u00e3o Brasileira de Sa\u00fade Coletiva (Abrasco), Sociedade Brasileira de Infectologia (SBInfecto), Sociedade Brasileira de Imunologia (SBI) e Sociedade Brasileira de Pediatria (SBP), foram avaliados o risco\/benef\u00edcio e a resposta imune da vacina.<\/p>\n<p style=\"text-align: justify\">O ensaio cl\u00ednico randomizado e duplo cego em estudo de fase II\/III da vacina Pfizer-BioNTec Covid-19 incluiu mais de 3.000 crian\u00e7as, que foram acompanhadas por pelo menos 7 dias. O imunizante demonstrou efic\u00e1cia de 90,9% (IC95%: 68,3-98,3%) contra Covid-19 sintom\u00e1tica.<\/p>\n<p style=\"text-align: justify\">O grupo de especialistas avaliou os dados dos estudos e resultados apresentados pelo laborat\u00f3rio e concluiu que os benef\u00edcios superam os riscos.<\/p>\n<p style=\"text-align: justify\">Al\u00e9m disso, foi sugerida um refor\u00e7o na sinaliza\u00e7\u00e3o dos frascos dos imunizantes e alertas educativos para informar sobre a diferen\u00e7a de dosagem. A vacina para crian\u00e7as de 5 a 11 anos de idade \u00e9 de 10 mcg e ser\u00e1 indicada com a tampa laranja, enquanto o imunizante de 30 mcg, aplicado a partir dos 12 anos de idade, ter\u00e1 tampa roxa.\u00a0A necessidade de farmacovigil\u00e2ncia por parte da empresa farmac\u00eautica tamb\u00e9m foi refor\u00e7ada.<\/p>\n<p style=\"text-align: justify\">A SBPT fez suas <a href=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/12\/Considerac\u0327o\u0303es_vacina_Pfizer_5-11anos.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">considera\u00e7\u00f5es<\/a> com a assessoria de profissionais do Instituto da Crian\u00e7a e do Adolescente do Hospital das Cl\u00ednicas da Faculdade de Medicina da USP (HCFMUSP), Dra. S\u00f4nia Regina da Silva Ramos e Dra. Helo\u00edsa Helena de Sousa Marques. Participou da reuni\u00e3o o coordenador do Departamento de Pneumologia Pedi\u00e1trica da SBPT, Dr. Luiz Vicente Ribeiro Silva Filho, juntamente com as profissionais do ICr-HCFMUSP.<\/p>\n<p style=\"text-align: justify\">A formula\u00e7\u00e3o infantil ser\u00e1 aplicada em duas doses, com pelo menos 21 dias de intervalo entre uma e outra.<\/p>\n<p style=\"text-align: justify\">A chegada do imunizante aos postos depende do calend\u00e1rio e da log\u00edstica do Programa Nacional de Imuniza\u00e7\u00f5es do Minist\u00e9rio da Sa\u00fade (PNI\/MS), que coordena a distribui\u00e7\u00e3o das vacinas por meio de programas p\u00fablicos no Brasil.<\/p>\n<p style=\"text-align: justify\"><a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/noticias-anvisa\/2021\/anvisa-aprova-vacina-da-pfizer-contra-covid-para-criancas-de-5-a-11-anos\" target=\"_blank\" rel=\"noopener noreferrer\">Leia a nota oficial no site da Anvisa.<\/a><\/p>\n<p style=\"text-align: justify\"><a href=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/12\/Considerac\u0327o\u0303es_vacina_Pfizer_5-11anos.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Leia o posicionamento do Instituto da Crian\u00e7a (HCFMUSP), redigido pela Prof\u00aa. S\u00f4nia da Silva Ramos e corroborado pela SBPT.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Na quinta-feira (16\/12), a Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou a indica\u00e7\u00e3o da vacina Comirnaty (Pfizer-BioNTech COVID-19, BNT162b2) para a imuniza\u00e7\u00e3o contra Covid-19 de crian\u00e7as de 5 a 11 anos de idade. Ap\u00f3s reuni\u00e3o realizada no dia 10\/12\/2021 com representantes da Anvisa e da Sociedade Brasileira de Pneumologia e Tisiologia (SBPT), Associa\u00e7\u00e3o Brasileira de [\u2026]","protected":false},"author":3,"featured_media":22471,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[68],"tags":[357,118,864,316],"class_list":["post-22464","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-anvisa","tag-covid-19","tag-pfizer","tag-vacina"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos<\/title>\n<meta name=\"description\" content=\"A Anvisa aprovou a indica\u00e7\u00e3o da vacina Comirnaty (Pfizer-BioNTech) para a imuniza\u00e7\u00e3o contra Covid-19 de crian\u00e7as de 5 a 11 anos de idade.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos\" \/>\n<meta property=\"og:description\" content=\"A Anvisa aprovou a indica\u00e7\u00e3o da vacina Comirnaty (Pfizer-BioNTech) para a imuniza\u00e7\u00e3o contra Covid-19 de crian\u00e7as de 5 a 11 anos de idade.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"sbpt.org.br\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pneumosbpt\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-16T19:38:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/12\/pch.vector-Freepik.png\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:site\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/\"},\"author\":{\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\"},\"headline\":\"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos\",\"datePublished\":\"2021-12-16T19:38:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/\"},\"wordCount\":409,\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/pch.vector-Freepik.png\",\"keywords\":[\"ANVISA\",\"COVID-19\",\"Pfizer\",\"vacina\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/\",\"name\":\"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/pch.vector-Freepik.png\",\"datePublished\":\"2021-12-16T19:38:14+00:00\",\"description\":\"A Anvisa aprovou a indica\u00e7\u00e3o da vacina Comirnaty (Pfizer-BioNTech) para a imuniza\u00e7\u00e3o contra Covid-19 de crian\u00e7as de 5 a 11 anos de idade.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/pch.vector-Freepik.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/pch.vector-Freepik.png\",\"width\":350,\"height\":255},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/anvisa-vacina-infantil-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"name\":\"sbpt.org.br\",\"description\":\"Sociedade Brasileira de Pneumologia e Tisiologia\",\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"alternateName\":\"SBPT\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\",\"name\":\"sbpt.org.br\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"width\":512,\"height\":512,\"caption\":\"sbpt.org.br\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pneumosbpt\",\"https:\\\/\\\/x.com\\\/pneumosbpt\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/socbraspneumol\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\",\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"caption\":\"Comunica\u00e7\u00e3o SBPT\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos","description":"A Anvisa aprovou a indica\u00e7\u00e3o da vacina Comirnaty (Pfizer-BioNTech) para a imuniza\u00e7\u00e3o contra Covid-19 de crian\u00e7as de 5 a 11 anos de idade.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos","og_description":"A Anvisa aprovou a indica\u00e7\u00e3o da vacina Comirnaty (Pfizer-BioNTech) para a imuniza\u00e7\u00e3o contra Covid-19 de crian\u00e7as de 5 a 11 anos de idade.","og_url":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/","og_site_name":"sbpt.org.br","article_publisher":"https:\/\/www.facebook.com\/pneumosbpt","article_published_time":"2021-12-16T19:38:14+00:00","og_image":[{"width":350,"height":255,"url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/12\/pch.vector-Freepik.png","type":"image\/png"}],"author":"Comunica\u00e7\u00e3o SBPT","twitter_card":"summary_large_image","twitter_creator":"@pneumosbpt","twitter_site":"@pneumosbpt","twitter_misc":{"Escrito por":"Comunica\u00e7\u00e3o SBPT","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/#article","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/"},"author":{"name":"Comunica\u00e7\u00e3o SBPT","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4"},"headline":"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos","datePublished":"2021-12-16T19:38:14+00:00","mainEntityOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/"},"wordCount":409,"publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/12\/pch.vector-Freepik.png","keywords":["ANVISA","COVID-19","Pfizer","vacina"],"articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/","url":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/","name":"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/12\/pch.vector-Freepik.png","datePublished":"2021-12-16T19:38:14+00:00","description":"A Anvisa aprovou a indica\u00e7\u00e3o da vacina Comirnaty (Pfizer-BioNTech) para a imuniza\u00e7\u00e3o contra Covid-19 de crian\u00e7as de 5 a 11 anos de idade.","breadcrumb":{"@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/#primaryimage","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/12\/pch.vector-Freepik.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/12\/pch.vector-Freepik.png","width":350,"height":255},{"@type":"BreadcrumbList","@id":"https:\/\/sbpt.org.br\/portal\/anvisa-vacina-infantil-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sbpt.org.br\/portal\/"},{"@type":"ListItem","position":2,"name":"Anvisa autoriza vacina da Pfizer para crian\u00e7as de 5 a 11 anos"}]},{"@type":"WebSite","@id":"https:\/\/sbpt.org.br\/portal\/#website","url":"https:\/\/sbpt.org.br\/portal\/","name":"sbpt.org.br","description":"Sociedade Brasileira de Pneumologia e Tisiologia","publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"alternateName":"SBPT","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sbpt.org.br\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sbpt.org.br\/portal\/#organization","name":"sbpt.org.br","url":"https:\/\/sbpt.org.br\/portal\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","width":512,"height":512,"caption":"sbpt.org.br"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pneumosbpt","https:\/\/x.com\/pneumosbpt","https:\/\/www.linkedin.com\/company\/pneumosbpt\/","https:\/\/www.instagram.com\/pneumosbpt\/","https:\/\/www.youtube.com\/user\/socbraspneumol"]},{"@type":"Person","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4","name":"Comunica\u00e7\u00e3o SBPT","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","caption":"Comunica\u00e7\u00e3o SBPT"}}]}},"_links":{"self":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/22464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/comments?post=22464"}],"version-history":[{"count":0,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/22464\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media\/22471"}],"wp:attachment":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media?parent=22464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/categories?post=22464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/tags?post=22464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}